New Findings on Acute Myeloid Leukemia Described by Investigators at Sloan Kettering Institute (Systematic Evaluation of Aml-associated Antigens Identifies Anti-u5 Snrnp200 Therapeutic Antibodies for the Treatment of Acute Myeloid Leukemia)

  • Benjamin Greenbaum

Press/Media

Period24 Nov 2023

Media coverage

1

Media coverage

  • TitleNew Findings on Acute Myeloid Leukemia Described by Investigators at Sloan Kettering Institute (Systematic Evaluation of Aml-associated Antigens Identifies Anti-u5 Snrnp200 Therapeutic Antibodies for the Treatment of Acute Myeloid Leukemia)
    Media name/outletNewsRx Hematology Daily
    Country/TerritoryUnited States
    Date24/11/23
    PersonsBenjamin Greenbaum